Baldirà, J.; Ruiz-Rodríguez, J.C.; Ruiz-Sanmartin, A.; Chiscano, L.; Cortes, A.; Sistac, D.Á.; Ferrer-Costa, R.; Comas, I.; Villena, Y.; Larrosa, M.N.;
et al. Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6. Biomedicines 2023, 11, 2149.
https://doi.org/10.3390/biomedicines11082149
AMA Style
Baldirà J, Ruiz-Rodríguez JC, Ruiz-Sanmartin A, Chiscano L, Cortes A, Sistac DÁ, Ferrer-Costa R, Comas I, Villena Y, Larrosa MN,
et al. Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6. Biomedicines. 2023; 11(8):2149.
https://doi.org/10.3390/biomedicines11082149
Chicago/Turabian Style
Baldirà, Jaume, Juan Carlos Ruiz-Rodríguez, Adolfo Ruiz-Sanmartin, Luis Chiscano, Alejandro Cortes, Diego Ángeles Sistac, Roser Ferrer-Costa, Inma Comas, Yolanda Villena, Maria Nieves Larrosa,
and et al. 2023. "Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6" Biomedicines 11, no. 8: 2149.
https://doi.org/10.3390/biomedicines11082149
APA Style
Baldirà, J., Ruiz-Rodríguez, J. C., Ruiz-Sanmartin, A., Chiscano, L., Cortes, A., Sistac, D. Á., Ferrer-Costa, R., Comas, I., Villena, Y., Larrosa, M. N., González-López, J. J., & Ferrer, R.
(2023). Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6. Biomedicines, 11(8), 2149.
https://doi.org/10.3390/biomedicines11082149
